Amphotericin B susceptibility testing of Candida species by flow cytometry.
We have developed an 8 hr flow cytometry (FCM) method for assessing susceptibility of yeasts to amphotericin B (AmpB). The method detects both high-level and relative-resistance to the drug. Variables found to affect fluorescence of control and AmpB treated cells included pH, presence of glucose, incubation conditions, concentration and length of exposure to both AmpB and ethidium bromide (ETBR), and the degree of resistance to AmpB. The FCM method was optimized based on increased red fluorescence intensity (RF), decreased forward angle light scatter (FALS), and a negative gating technique. A dose response was seen between 0.1 and 10 micrograms AmpB/ml for the susceptible control strain. Greater than 50% of cells from all susceptible strains tested transfer into the negative gate when exposed to 2.5 micrograms Amp B/ml while fewer than 5% of cells of the highly resistant C. tropicalis (ATCC 28707) are affected at concentrations up to 20 micrograms/ml. This method may provide a more accurate assessment of Amp B susceptibility than conventional tube dilution methods.
O'Gorman
M R
MR
Department of Hospital Laboratories, Clinical Microbiology and Immunology, UNC Hospitals, Chapel Hill 27514.
Hopfer
R L
RL
D000666:Amphotericin B / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects*; D015169:Colony Count, Microbial; D004352:Drug Resistance, Microbial; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015203:Reproducibility of Results
D000666:Amphotericin B